Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Articles published by Profound Medical Corp. Profound Medical to Release Second Quarter 2024 Financial Results on August 8 – Conference Call to Follow July 18, 2024 From Profound Medical Corp. Via GlobeNewswire Tickers PROF TSX:PRN Profound Medical Announces Category 1 CPT Codes Proposed CY2025 Rule for TULSA to Treat Prostate Diseases July 11, 2024 From Profound Medical Corp. Via GlobeNewswire Tickers PROF TSX:PRN Profound Medical Annual General Meeting of Shareholders Voting Results May 15, 2024 From Profound Medical Corp. Via GlobeNewswire Tickers PROF TSX:PRN Profound Medical Receives U.S. FDA 510(k) Clearance for ‘Contouring Assistant’ AI Module that Enables Creation of an Automated TULSA Treatment Plan May 14, 2024 From Profound Medical Corp. Via GlobeNewswire Tickers PROF TSX:PRN Profound Medical Announces First Quarter 2024 Financial Results and Issues Full-Year 2024 Revenue Guidance May 09, 2024 From Profound Medical Corp. Via GlobeNewswire Tickers PROF TSX:PRN Growing Body of Clinical Evidence Points to the Potential of Profound Medical’s TULSA Procedure Becoming a Mainstream Treatment Modality Across the Entire Prostate Disease Spectrum May 06, 2024 From Profound Medical Corp. Via GlobeNewswire Tickers PROF TSX:PRN Profound Medical to Release First Quarter 2024 Financial Results on May 9 – Conference Call to Follow April 22, 2024 From Profound Medical Corp. Via GlobeNewswire Tickers PROF TSX:PRN Profound Medical to Participate in the 2024 Bloom Burton & Co. Healthcare Investor Conference April 09, 2024 From Profound Medical Corp. Via GlobeNewswire Tickers PROF TSX:PRN Profound Medical Announces Fourth Quarter and Full Year 2023 Financial Results March 07, 2024 From Profound Medical Corp. Via GlobeNewswire Tickers PROF TSX:PRN Profound Medical to Participate in Barclays 26th Annual Global Healthcare Conference March 04, 2024 From Profound Medical Corp. Via GlobeNewswire Tickers PROF TSX:PRN Profound Medical in Collaboration with Siemens Healthineers to Further Expand Physician and Patient Access to the TULSA Procedure February 27, 2024 From Profound Medical Corp. Via GlobeNewswire Tickers PROF TSX:PRN Profound Medical to Release Fourth Quarter and Full Year 2023 Financial Results on March 7 – Conference Call to Follow February 15, 2024 From Profound Medical Corp. Via GlobeNewswire Tickers PROF TSX:PRN Profound Medical Announces Non-Brokered Private Placement January 16, 2024 From Profound Medical Corp. Via GlobeNewswire Tickers PROF TSX:PRN Profound Medical Announces Preliminary Unaudited Fourth Quarter and Full Year 2023 Revenues January 03, 2024 From Profound Medical Corp. Via GlobeNewswire Tickers PROF TSX:PRN Profound Medical Announces Pricing of US$20 Million Public Offering of Common Shares December 27, 2023 From Profound Medical Corp. Via GlobeNewswire Tickers PROF TSX:PRN Profound Medical Announces Proposed Public Offering of Common Shares December 27, 2023 From Profound Medical Corp. Via GlobeNewswire Tickers PROF TSX:PRN Profound Medical to Participate in the Stifel 2023 Healthcare Conference November 08, 2023 From Profound Medical Corp. Via GlobeNewswire Tickers PROF TSX:PRN Profound Medical Announces CMS Extension of Temporary ‘Code’ for TULSA to ASC Setting November 03, 2023 From Profound Medical Corp. Via GlobeNewswire Tickers PROF TSX:PRN Profound Medical Announces Third Quarter 2023 Financial Results November 02, 2023 From Profound Medical Corp. Via GlobeNewswire Tickers PROF TSX:PRN Profound Medical to Release Third Quarter 2023 Financial Results on November 2 – Conference Call to Follow October 19, 2023 From Profound Medical Corp. Via GlobeNewswire Tickers PROF TSX:PRN Profound Medical 2023 Virtual Analyst & Investor Day Agenda October 10, 2023 From Profound Medical Corp. Via GlobeNewswire Tickers PROF TSX:PRN Profound Medical Receives U.S. FDA 510(k) Clearance for TULSA-PRO® Thermal Boost September 25, 2023 From Profound Medical Corp. Via GlobeNewswire Tickers PROF TSX:PRN Save the Date: Profound Medical to Host Virtual Analyst & Investor Day on October 13 September 21, 2023 From Profound Medical Corp. Via GlobeNewswire Tickers PROF TSX:PRN Profound Medical to Participate in the 2023 Cantor Global Healthcare Conference September 19, 2023 From Profound Medical Corp. Via GlobeNewswire Tickers PROF TSX:PRN Profound Medical Announces At-the-Market Offering of up to US$30,000,000 September 06, 2023 From Profound Medical Corp. Via GlobeNewswire Tickers PROF TSX:PRN Profound Medical Announces Second Quarter 2023 Financial Results August 09, 2023 From Profound Medical Corp. Via GlobeNewswire Tickers PROF TSX:PRN Profound Medical to Release Second Quarter 2023 Financial Results on August 9 – Conference Call to Follow August 02, 2023 From Profound Medical Corp. Via GlobeNewswire Tickers PROF TSX:PRN Profound Medical Announces New CPT® Category 1 Codes from the AMA for TULSA to Treat Prostate Diseases June 02, 2023 From Profound Medical Corp. Via GlobeNewswire Tickers PROF TSX:PRN Profound Medical Announces Upcoming Investor Events May 30, 2023 From Profound Medical Corp. Via GlobeNewswire Tickers PROF TSX:PRN Profound Medical to Participate in A.G.P.’s Virtual Healthcare Conference May 18, 2023 From Profound Medical Corp. Via GlobeNewswire Tickers PROF TSX:PRN Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.